| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0016-5107(04)01710-9 |
| P698 | PubMed publication ID | 15332019 |
| P50 | author | Alastair Forbes | Q58459763 |
| Michael A. Kamm | Q91050016 | ||
| P2093 | author name string | Matthew D Rutter | |
| Brian P Saunders | |||
| Christopher B Williams | |||
| Kay H Wilkinson | |||
| P2860 | cites work | Cancer risk in patients with inflammatory bowel disease | Q33662068 |
| Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years | Q34392483 | ||
| Cancer in inflammatory bowel disease. An evidence-based analysis and guide for physicians and patients | Q34745661 | ||
| Rectal biopsy as an aid to cancer control in ulcerative colitis | Q35003642 | ||
| Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. | Q35598279 | ||
| Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease | Q40423721 | ||
| Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? | Q40619445 | ||
| DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. | Q41104513 | ||
| Colonic chromoscopy. A new perspective on polyps and flat adenomas. | Q41492669 | ||
| Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. | Q42793428 | ||
| Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. | Q45204242 | ||
| Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. | Q50714369 | ||
| Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps | Q63407681 | ||
| Precancer and carcinoma in chronic ulcerative colitis. A histopathological and clinical investigation | Q68651886 | ||
| DALM in ulcerative colitis cancer surveillance | Q69514588 | ||
| High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening | Q71035683 | ||
| Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis | Q71652927 | ||
| Cancer surveillance in ulcerative colitis. Experience over 15 years | Q72556204 | ||
| Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis | Q73223728 | ||
| ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy? | Q73223775 | ||
| Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients | Q74310740 | ||
| The role of colonoscopy in the management of patients with inflammatory bowel disease. American Society for Gastrointestinal Endoscopy | Q77679462 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ulcerative colitis | Q1477 |
| colonoscopy | Q840387 | ||
| P304 | page(s) | 334-339 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Gastrointestinal Endoscopy | Q15724481 |
| P1476 | title | Most dysplasia in ulcerative colitis is visible at colonoscopy | |
| P478 | volume | 60 |
| Q50034495 | A Randomized Trial Comparing High Definition Colonoscopy Alone With High Definition Dye Spraying and Electronic Virtual Chromoendoscopy for Detection of Colonic Neoplastic Lesions During IBD Surveillance Colonoscopy. |
| Q41059967 | A practical guide and review of colonoscopic surveillance and chromoendoscopy in patients with colitis |
| Q42149870 | Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer |
| Q37419395 | Adherence to guidelines for surveillance colonoscopy in patients with ulcerative colitis at a Canadian quaternary care hospital |
| Q41642099 | Advanced imaging in colonoscopy: contemporary approach to dysplasia surveillance in inflammatory bowel disease. |
| Q51743145 | An Update on Surveillance in Ulcerative Colitis. |
| Q40051821 | An updated approach to dysplasia in IBD. |
| Q82824080 | Atypical rectal bleeding: the challenge of diagnosing mild ulcerative colitis |
| Q53316460 | Autofluorescence imaging colonoscopy for the detection of dysplastic lesions in ulcerative colitis: a pilot study. |
| Q37448141 | CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes |
| Q34017478 | Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. |
| Q34150651 | Cancer surveillance strategies in ulcerative colitis: the need for modernization |
| Q36730967 | Chromoendoscopy Is Better: So Why Am I Not (yet) Using it for Routine Inflammatory Bowel Disease Surveillance? |
| Q37130029 | Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future |
| Q50215957 | Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study |
| Q38238980 | Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease |
| Q26778018 | Colitis-associated colon cancer: Is it in your genes? |
| Q39904958 | Colon cancer in inflammatory bowel disease: recent trends, questions and answers. |
| Q38288038 | Colon cancer screening and surveillance in inflammatory bowel disease. |
| Q34079768 | Colonoscopic surveillance in inflammatory bowel disease: state of the art reduction of biopsies |
| Q38662465 | Colorectal Cancer Screening in Inflammatory Bowel Disease. |
| Q36281579 | Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance |
| Q22241218 | Colorectal cancer and dysplasia in inflammatory bowel disease |
| Q38273304 | Colorectal cancer in colitis: a relic of the past? |
| Q34508778 | Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis |
| Q92759068 | Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments |
| Q55387241 | Colorectal dysplasia and adenocarcinoma in patients with ulcerative colitis: an experience from a tertiary care hospital. |
| Q44450427 | Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease |
| Q38255045 | Current issues in inflammatory bowel disease neoplasia |
| Q57071771 | DALM, rest in peace: a pathologist's perspective on dysplasia in inflammatory bowel disease in the post-DALM era |
| Q26825735 | Detection of nonpolypoid colorectal neoplasia using magnifying endoscopy in colonic inflammatory bowel disease |
| Q37305789 | Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon |
| Q48364890 | Diagnostic dilemmas in chronic inflammatory bowel disease |
| Q37480804 | Dysplasia and colitis |
| Q38687411 | Dysplasia and colorectal cancer surveillance in inflammatory bowel disease |
| Q37783963 | Dysplastic lesions in ulcerative colitis: Changing paradigms |
| Q55185963 | Early detection of ulcerative colitis-associated colorectal cancer. |
| Q93048973 | Endocuff Vision is safe to use for dysplasia surveillance in patients with ulcerative colitis: a feasibility study |
| Q88457981 | Endoscopic Diagnosis and Treatment of Precancerous Colorectal Lesions in Patients with Inflammatory Bowel Disease: How Does the Latest SCENIC International Consensus Intersect with Our Clinical Practice? |
| Q88208231 | Endoscopic Surveillance in Inflammatory Bowel Disease |
| Q46076755 | Endoscopic Surveillance in Long-standing Colitis |
| Q42699714 | Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease |
| Q26777718 | Endoscopic Therapy in Inflammatory Bowel Diseases |
| Q36987084 | Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis |
| Q37601306 | Endoscopic and pathological aspects of colitis-associated dysplasia |
| Q37094727 | Endoscopic evaluation of patients with inflammatory bowel disease |
| Q36930803 | Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. |
| Q46690820 | European consensus on the histopathology of inflammatory bowel disease. |
| Q38159096 | European evidence based consensus for endoscopy in inflammatory bowel disease |
| Q40036311 | Evaluation and Detection of Dysplasia in IBD: the Role of Chromoendoscopy and Enhanced Imaging Techniques |
| Q38099526 | Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis. |
| Q91160350 | Improving the quality of surveillance colonoscopy in inflammatory bowel disease |
| Q26774592 | Inflammatory bowel disease associated neoplasia: A surgeon's perspective |
| Q38064742 | Inflammatory bowel disease cancer risk, detection and surveillance |
| Q37024833 | Inflammatory bowel disease: the problems of dysplasia and surveillance |
| Q26826827 | Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines |
| Q43979208 | Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis? |
| Q57832665 | Large bowel cancer in the setting of inflammatory bowel disease |
| Q37796349 | Management of High-Risk Colonoscopy Patients |
| Q37987478 | Managing risks of neoplasia in inflammatory bowel disease |
| Q33994161 | Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect |
| Q38201709 | Microscopic features of colorectal neoplasia in inflammatory bowel diseases |
| Q48053770 | Near-Infrared Fluorescence Endoscopy to Detect Dysplastic Lesions in the Mouse Colon |
| Q35567602 | Non-polypoid colorectal neoplasms: Classification, therapy and follow-up |
| Q40654642 | Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection |
| Q53805081 | Polypectomy versus proctocolectomy for adenoma patients with long-standing ulcerative colitis. |
| Q37058852 | Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease |
| Q36110108 | Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines |
| Q34390271 | Recent advancement in understanding colitis-associated tumorigenesis |
| Q36589428 | Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing? |
| Q36589424 | Review article: what are the important endoscopic lesions for detection of dysplasia in inflammatory bowel disease? |
| Q43072226 | Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies |
| Q39586244 | Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer |
| Q38049779 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations |
| Q57795305 | Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis |
| Q38085174 | Strategies for detecting colon cancer and dysplasia in patients with inflammatory bowel disease |
| Q24246110 | Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease |
| Q47966879 | Strategies for detecting colon cancer in patients with inflammatory bowel disease. |
| Q38533703 | Surveillance colonoscopy for colitis-associated dysplasia and cancer in ulcerative colitis patients |
| Q52898815 | Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. |
| Q50534656 | Surveillance for colorectal cancer in patients with inflammatory bowel disease. |
| Q50222491 | Surveillance in ulcerative colitis: is chromoendoscopy-guided endomicroscopy always better than conventional colonoscopy? A randomized trial. |
| Q37327836 | Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. |
| Q36655654 | Surveillance of dysplasia in inflammatory bowel disease: The gastroenterologist-pathologist partnership |
| Q84961675 | Surveillance programmes for neoplasia in colitis |
| Q60151645 | The histopathological approach to inflammatory bowel disease: a practice guide |
| Q38224247 | The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease |
| Q44748462 | The present status and problems with diagnosis and management of dysplasia/colitic cancer in ulcerative colitis |
| Q53365564 | The world isn't flat. |
| Q35781294 | Ulcerative Colitis: Update on Medical Management |
| Q44958286 | Ulcerative colitis patients with dysplastic polyps should be advised to undergo colectomy |
| Q41477418 | Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease |
| Q44917989 | What are the guidelines for treating adenoma-like DALMs in UC? |
Search more.